Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2011 3
2015 2
2016 1
2017 2
2018 4
2019 8
2020 5
2021 7
2022 7
2023 8
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

47 results

Results by year

Filters applied: . Clear all
Page 1
International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma.
Travis WD, Brambilla E, Noguchi M, Nicholson AG, Geisinger KR, Yatabe Y, Beer DG, Powell CA, Riely GJ, Van Schil PE, Garg K, Austin JH, Asamura H, Rusch VW, Hirsch FR, Scagliotti G, Mitsudomi T, Huber RM, Ishikawa Y, Jett J, Sanchez-Cespedes M, Sculier JP, Takahashi T, Tsuboi M, Vansteenkiste J, Wistuba I, Yang PC, Aberle D, Brambilla C, Flieder D, Franklin W, Gazdar A, Gould M, Hasleton P, Henderson D, Johnson B, Johnson D, Kerr K, Kuriyama K, Lee JS, Miller VA, Petersen I, Roggli V, Rosell R, Saijo N, Thunnissen E, Tsao M, Yankelewitz D. Travis WD, et al. J Thorac Oncol. 2011 Feb;6(2):244-85. doi: 10.1097/JTO.0b013e318206a221. J Thorac Oncol. 2011. PMID: 21252716 Free PMC article. Review.
CONCLUSIONS: This new classification strategy is based on a multidisciplinary approach to diagnosis of lung adenocarcinoma that incorporates clinical, molecular, radiologic, and surgical issues, but it is primarily based on histology. ...As EGFR mutation is a valida …
CONCLUSIONS: This new classification strategy is based on a multidisciplinary approach to diagnosis of lung adenocarcinoma tha …
Prognostic factors for invasive mucinous adenocarcinoma of the lung: systematic review and meta-analysis.
Zhao T, Yi J, Luo D, Liu J, Fan X, Wu Q, Wang W. Zhao T, et al. World J Surg Oncol. 2024 Feb 2;22(1):41. doi: 10.1186/s12957-024-03326-4. World J Surg Oncol. 2024. PMID: 38303008 Free PMC article.
BACKGROUND: Invasive mucinous adenocarcinoma of the lung (IMA) is a unique and rare subtype of lung adenocarcinoma with poorly defined prognostic factors and highly controversial studies. ...
BACKGROUND: Invasive mucinous adenocarcinoma of the lung (IMA) is a unique and rare subtype of lung adenocarcinoma with poorly …
Human papillomavirus infection as a prognostic marker for lung adenocarcinoma: a systematic review and meta-analysis.
Guo L, Liu S, Zhang S, Chen Q, Zhang M, Quan P, Sun X. Guo L, et al. Oncotarget. 2017 May 23;8(21):34507-34515. doi: 10.18632/oncotarget.15671. Oncotarget. 2017. PMID: 28427144 Free PMC article. Review.
The pooled hazard ratio (HR) comparing HPV-positive to HPV-negative cancers 1.00 (95% confidence interval (CI): 0.78-1.28) was not significantly correlated with overall survival. However, lung adenocarcinoma patients with HPV infections exhibited a survival benefit …
The pooled hazard ratio (HR) comparing HPV-positive to HPV-negative cancers 1.00 (95% confidence interval (CI): 0.78-1.28) was not significa …
Outcome of patients with lung adenocarcinoma with transformation to small-cell lung cancer following tyrosine kinase inhibitors treatment: A systematic review and pooled analysis.
Roca E, Gurizzan C, Amoroso V, Vermi W, Ferrari V, Berruti A. Roca E, et al. Cancer Treat Rev. 2017 Sep;59:117-122. doi: 10.1016/j.ctrv.2017.07.007. Epub 2017 Jul 31. Cancer Treat Rev. 2017. PMID: 28806542 Review.
BACKGROUND: Lung adenocarcinoma can transform to small-cell lung cancer (SCLC) when resistance to tyrosine kinase inhibitors (TKIs) develops. ...CONCLUSION: In this series of published cases, the transformation to a SCLC phenotype after an initial diagnosis of lu …
BACKGROUND: Lung adenocarcinoma can transform to small-cell lung cancer (SCLC) when resistance to tyrosine kinase inhibitors ( …
Golimumab and malignancies: true or false association?
Zidi I, Bouaziz A, Mnif W, Bartegi A, Ben Amor N. Zidi I, et al. Med Oncol. 2011 Jun;28(2):641-8. doi: 10.1007/s12032-010-9490-7. Epub 2010 Apr 7. Med Oncol. 2011. PMID: 20373059 Review.
The most frequent cancer in patients treated with golimumab, in association or not with methotrexate, is the lung adenocarcinoma. However, lymphoma is not very commonly represented in these patients. ...
The most frequent cancer in patients treated with golimumab, in association or not with methotrexate, is the lung adenocarcinoma …
Prognostic value of consolidation-to-tumor ratio on computed tomography in NSCLC: a meta-analysis.
Wu Y, Song W, Wang D, Chang J, Wang Y, Tian J, Zhou S, Dong Y, Zhou J, Li J, Zhao Z, Che G. Wu Y, et al. World J Surg Oncol. 2023 Jun 22;21(1):190. doi: 10.1186/s12957-023-03081-y. World J Surg Oncol. 2023. PMID: 37349739 Free PMC article. Review.
According to subgroup analysis by the cut-off value of CTR and histology type, both lung adenocarcinoma and NSCLC patients who had a higher CTR showed worse survival. ...
According to subgroup analysis by the cut-off value of CTR and histology type, both lung adenocarcinoma and NSCLC patients who …
Diagnostic and prognostic value of microRNA-486 in patients with lung cancer: A systematic review and meta-analysis.
Shen X, Li L, Zhang L, Liu W, Wu Y, Ma R. Shen X, et al. Int J Biol Markers. 2022 Dec;37(4):377-385. doi: 10.1177/03936155221115750. Epub 2022 Jul 28. Int J Biol Markers. 2022. PMID: 35902998 Free article.
Results of subgroup analysis showed that high diagnostic efficacy might be obtained by miR-486 combined with other microRNAs (area under the curve (AUC): 0.9 (0.9-1.0)) to distinguish lung cancer patients from healthy controls (AUC: 1.0 (0.9-1.0)), especially for lung a …
Results of subgroup analysis showed that high diagnostic efficacy might be obtained by miR-486 combined with other microRNAs (area under the …
The role of mir-151a-5p in tumorigenesis; A systematic review.
Ebrahimi A, Derakhshan SM, Ghavi D, Foruzandeh Z, Hashemi S. Ebrahimi A, et al. Pathol Res Pract. 2023 Sep;249:154576. doi: 10.1016/j.prp.2023.154576. Epub 2023 Jun 1. Pathol Res Pract. 2023. PMID: 37562284 Review.
Pituitary adenomas, Barrett's carcinogenesis and CNS lymphomas are top cancers diagnosed with mir-151-5p. However, prognostic feature is only applicable to Lung adenocarcinoma. DISCUSSION: Based on the present findings and further studies in the future, mir-151a-5p …
Pituitary adenomas, Barrett's carcinogenesis and CNS lymphomas are top cancers diagnosed with mir-151-5p. However, prognostic feature is onl …
Anti-Hu Antibodies in Patients With Neurologic Side Effects of Immune Checkpoint Inhibitors.
Farina A, Villagrán-García M, Ciano-Petersen NL, Vogrig A, Muñiz-Castrillo S, Taillandier L, Michaud M, Lefilliatre M, Wang A, Lepine Z, Picard G, Wucher V, Dhairi M, Fabien N, Goncalves D, Rogemond V, Joubert B, Honnorat J. Farina A, et al. Neurol Neuroimmunol Neuroinflamm. 2022 Nov 29;10(1):e200058. doi: 10.1212/NXI.0000000000200058. Print 2023 Jan. Neurol Neuroimmunol Neuroinflamm. 2022. PMID: 36446613 Free PMC article.
RESULTS: Eleven patients with Hu-Ab and n-irAEs were included (median age, 66 years, range 44-76 years; 73% men). Ten patients had small cell lung cancer, and 1 had lung adenocarcinoma. The median follow-up from onset was 3 months (range 0.5-18 months). ...
RESULTS: Eleven patients with Hu-Ab and n-irAEs were included (median age, 66 years, range 44-76 years; 73% men). Ten patients had small cel …
Prognostic implications of programmed death ligand 1 expression in resected lung adenocarcinoma: a systematic review and meta-analysis.
Chen D, Mao Y, Ding Q, Wang W, Zhu F, Chen C, Chen Y. Chen D, et al. Eur J Cardiothorac Surg. 2020 Nov 1;58(5):888-898. doi: 10.1093/ejcts/ezaa172. Eur J Cardiothorac Surg. 2020. PMID: 32596715
OBJECTIVES: Conflicting results have been reported about the prognostic value of programmed death ligand 1 (PD-L1) protein and gene expression in lung adenocarcinoma. METHODS: We performed a comprehensive online search to explore the association between PD-L1 expres …
OBJECTIVES: Conflicting results have been reported about the prognostic value of programmed death ligand 1 (PD-L1) protein and gene expressi …
47 results